SCHEMBL24401161

SCHEMBL24401161

CCOC(=O)c1cc2[nH]c(C=C3CCN(C(=O)OC(C)(C)C)CC3)nc2s1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.44
GRM5 P41594 2/20 0.39
ALOX15 P16050 1/20 0.38
ACKR3 P25106 3/20 0.37
ATM Q13315 1/20 0.37
GPR119 Q8TDV5 2/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24401166 0.74 ADORA1 (0.39) ADORA1GRM5GPR119TP53POLB
SCHEMBL24400818 0.74 ADORA1 (0.38) ADORA1GRM5ACKR3ATMGPR119
SCHEMBL1775683 0.71 ADORA1 (0.43) ADORA1GRM5ACKR3ATMGPR119
SCHEMBL4033844 0.71 ATM (0.48) ADORA1GRM5ATMGPR119ALDH1A1
SCHEMBL24401162 0.71 ADORA1 (0.39) ADORA1GRM5ALOX15GPR119TP53
SCHEMBL6298972 0.71 MAPT (0.48) ALOX15ATMPOLBALDH1A1MEN1
SCHEMBL19329569 0.69 TP53 (0.42) ADORA1GRM5ATMGPR119TP53
SCHEMBL26107555 0.69 ACKR3 (0.44) ADORA1ACKR3ATMTP53POLB
SCHEMBL1174301 0.69 ADORA1 (0.57) ADORA1ALDH1A1NPSR1LMNASMN1; SMN2
SCHEMBL980137 0.69 ADORA1 (0.60) ADORA1ALOX15ALDH1A1NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203057-A1 FIVE-MEMBERED HETEROAROMATIC IMIDAZOLE COMPOUND AND USE THEREOF HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2023-06-29 US disclosed
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2023-01-03 US disclosed
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof HANGZHOU SCIWIND BIOSCIENCES CO., LTD (CN) 2022-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135588-A1 Five-Membered Heteroaryl-Fused Imidazole Compound And Application Thereof GLP1R, GIPR, GPR119 ADORA1 1439/4885GRM5 259/4885ALOX15 2801/4885
US-20230203057-A1 FIVE-MEMBERED HETEROAROMATIC IMIDAZOLE COMPOUND AND USE THEREOF GLP1R, GIPR, GPR119 ADORA1 1083/4885GRM5 256/4885ALOX15 2699/4885
US-11542272-B2 Five-membered heteroaryl-fused imidazole compound and application thereof GLP1R, GIPR, GPR119 ADORA1 1439/4885GRM5 259/4885ALOX15 2801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.